Mark Froimson

Track

Insider profile

Currently holds a position at Pacira BioSciences, Inc.

Performance

Overall performance
3.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 50% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 88%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Director Pacira BioSciences, Inc. Jan. 1, 2018 -
Director Pacira BioSciences, Inc. June 14, 2017 - Jan. 1, 2018
Mark Froimson's trades of Pacira BioSciences, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
92.13
Quantity 7,085 -8.0%
Value US$1,616,945
Transaction date
Proposed sale
Price
99.78
Quantity 29,820
Value US$1,832,376
Transaction date
Purchase
Price
221.17
Quantity 37,726 +21.8%
Value US$3,484,837
Transaction date
Sale
Price
72.26
Quantity 734 -12.3%
Value US$53,039
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-19 2026-03-17
S Sale
7,085 -8.0%
92.13
US$1,616,945 		7,085 -8.0% 92.13 US$1,616,945
2026-03-17 2026-03-17
PrS Proposed sale
29,820
99.78
US$1,832,376 		29,820 99.78 US$1,832,376
2024-08-12 2024-08-12
B Purchase
37,726 +21.8%
221.17
US$3,484,837 		37,726 +21.8% 221.17 US$3,484,837
2022-05-11 2022-05-09
S Sale
1,000 -16.9%
59.37
US$59,370 		1,000 -16.9% 59.37 US$59,370
2021-03-17 2021-03-15
S Sale
734 -12.3%
72.26
US$53,039 		734 -12.3% 72.26 US$53,039